The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
N2M2/NOA-20: Phase I/IIa umbrella trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation.
 
Wolfgang Wick
Consulting or Advisory Role - GlaxoSmithKline; MSD Oncology (Inst); Roche/Genentech (Inst); SERVIER
Research Funding - Apogenix (Inst); Pfizer (Inst); Roche (Inst)
 
Lisa-Marie Lanz
No Relationships to Disclose
 
Antje Wick
No Relationships to Disclose
 
Inga Harting
No Relationships to Disclose
 
Susan Dettmer
No Relationships to Disclose
 
Abigail k Suwala
No Relationships to Disclose
 
Ralf Ketter
No Relationships to Disclose
 
Ghazaleh Tabatabai
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis (Inst); Bayer Germany (Inst); Boehringer Ingelheim (Inst); CureVac (Inst)
 
Corinna Seliger-Behme
No Relationships to Disclose
 
Martin Glas
Consulting or Advisory Role - Novartis; Novocure; Seagen; SERVIER
Research Funding - Novocure (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Novocure
 
Michael C Burger
No Relationships to Disclose
 
Marco Timmer
No Relationships to Disclose
 
Florian A Ringel
No Relationships to Disclose
 
Iris Mildenberger
No Relationships to Disclose
 
Walter J Schulz-Schaeffer
No Relationships to Disclose
 
Mirjam Renovanz
No Relationships to Disclose
 
Martin Bendszus
No Relationships to Disclose
 
Felix Sahm
Stock and Other Ownership Interests - Heidelberg Epignostix GmbH
Honoraria - Illumina
Consulting or Advisory Role - Bayer
Speakers' Bureau - 10xgenomics
 
Michael Platten
Stock and Other Ownership Interests - Evotech
Consulting or Advisory Role - Monte Rosa Therapeutics (Inst); Novartis (Inst)
Research Funding - Bayer (Inst); Merck KGaA (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - AHR Antagonists; H-.3 mutated cancer vaccine; IDH Vaccine
 
Tobias Kessler
No Relationships to Disclose